...
首页> 外文期刊>Microbial Ecology in Health and Disease >Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders
【24h】

Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders

机译:肠道微生物组的短链脂肪酸发酵产物:对自闭症谱系障碍的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Recent evidence suggests potential, but unproven, links between dietary, metabolic, infective, and gastro-intestinal factors and the behavioral exacerbations and remissions of autism spectrum disorders (ASDs).Propionic acid (PPA) and its related short-chain fatty acids (SCFAs) are fermentation products of ASD-associated bacteria (Clostridia, Bacteriodetes, Desulfovibrio). SCFAs represent a group of compounds derivedfrom the host microbiome that are plausibly linked to ASDs and can induce widespread effects on gut, brain,and behavior. Intraventricular administration of PPA and SCFAs in rats induces abnormal motor movements,repetitive interests, electrographic changes, cognitive deficits, perseveration, and impaired social interactions.The brain tissue of PPA-treated rats shows a number of ASD-linked neurochemical changes, including innateneuroinflammation, increased oxidative stress, glutathione depletion, and altered phospholipid/acylcarnitineprofiles. These directly or indirectly contribute to acquired mitochondrial dysfunction via impairment incarnitine-dependent pathways, consistent with findings in patients with ASDs. Of note, common antibioticsmay impair carnitine-dependent processes by altering gut flora favoring PPA-producing bacteria and bydirectly inhibiting carnitine transport across the gut. Human populations that are partial metabolizers of PPAare more common than previously thought. PPA has further bioactive effects on neurotransmitter systems,intracellular acidification/calcium release, fatty acid metabolism, gap junction gating, immune function,and alteration of gene expression that warrant further exploration. These findings are consistent with thesymptoms and proposed underlying mechanisms of ASDs and support the use of PPA infusions in ratsas a valid animal model of the condition. Collectively, this offers further support that gut-derived factors,such as dietary or enteric bacterially produced SCFAs, may be plausible environmental agents that can triggerASDs or ASD-related behaviors and deserve further exploration in basic science, agriculture, and clinicalmedicine.
机译:最近的证据表明,饮食,代谢,感染性和胃肠道因素与自闭症谱系障碍(ASD)的行为恶化和缓解之间存在潜在但未经证实的联系。丙酸(PPA)及其相关的短链脂肪酸(SCFA) )是与ASD相关的细菌(梭菌,拟杆菌,脱硫弧菌)的发酵产物。 SCFAs代表一组衍生自宿主微生物组的化合物,这些化合物似乎与ASD相连,并且可以诱导对肠道,大脑和行为的广泛影响。在大鼠的脑室内施用PPA和SCFA会诱发异常的运动动作,重复兴趣,电子描记图变化,认知缺陷,坚持不懈和社交互动受损。用PPA处理的大鼠的脑组织显示出许多与ASD相关的神经化学变化,包括先天性神经炎,增加氧化应激,谷胱甘肽耗竭和改变磷脂/酰基肉碱轮廓。这些通过损害肉碱依赖性途径直接或间接地导致获得性线粒体功能障碍,与ASD患者的发现一致。值得注意的是,常见的抗生素可能会通过改变有利于生产PPA的细菌的肠道菌群并直接抑制肉碱在肠道内的运输而损害肉碱依赖性过程。作为PPA的部分代谢产物的人群比以前认为的更为普遍。 PPA对神经递质系统,细胞内酸化/钙释放,脂肪酸代谢,间隙连接门控,免疫功能以及基因表达的改变具有进一步的生物活性,值得进一步研究。这些发现与症状和拟议的ASD的潜在机制相一致,并支持在大鼠中使用PPA输注作为该病的有效动物模型。总的来说,这进一步支持了肠源性因素,例如饮食或肠内细菌产生的SCFA,可能是可能触发ASD或ASD相关行为的环境因素,值得在基础科学,农业和临床医学中进行进一步的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号